Develop A Treatment That Combines Novel Gastrointestinal Radioprotectant With Precision Radiotherapy To Increase The Effectiveness Of Treating Pancreatic Cancer.

XERIENT PHARMA Israel has Released a tender for Develop A Treatment That Combines Novel Gastrointestinal Radioprotectant With Precision Radiotherapy To Increase The Effectiveness Of Treating Pancreatic Cancer. in . The tender was released on Jan 01, 1970.

Country - Israel

Summary - Develop A Treatment That Combines Novel Gastrointestinal Radioprotectant With Precision Radiotherapy To Increase The Effectiveness Of Treating Pancreatic Cancer.

Deadline - Dec 31, 2024

MT reference number - 10825379

Product classification -

Organization Details:

  Address - Israel

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10825379

  Document Type - Tender Notices

Login

Notice Details and Documents:

Description - Scope ; Xerient Pharma (Petach Tikva, Israel), and Accuray (Madison, WI), who will develop a treatment that combines novel gastrointestinal radioprotectant with precision radiotherapy to increase the effectiveness of treating pancreatic cancer Medical Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

Mt Ref Id - 10825379

Deadline - Dec 31, 2024

Login

Share

View more tenders for

Israel Tenders

Most Searched